Cardiotoxicity is a relatively frequent and potentially serious side effect of traditional and
targeted cancer therapies. Both general measures and specific pharmacologic …

Cardiovascular disease is a competing cause of death in patients with cancer with early-
stage disease. This elevated cardiovascular disease risk is thought to derive from both the …

Disruption of systemic homeostasis by either chronic or acute stressors, such as obesity or
surgery, alters cancer pathogenesis. Patients with cancer, particularly those with breast …

Answer questions and earn CME/CNE Colorectal cancer (CRC) is the third most common
cancer and third leading cause of cancer death in both men and women and second leading …

Importance There is increasing interest in the effect of cardiovascular disease on cancer
survivors. However, there are limited contemporary population-based data on the risk of …

Background: Adjuvant breast cancer therapy containing anthracyclines with or without anti–
human epidermal growth factor receptor–2 antibodies and radiotherapy is associated with …

In the United States alone, there are currently approximately 14.5 million cancer survivors,
and this number is expected to increase to 20 million by 2020. Cancer therapies can cause …

Purpose To evaluate cardiopulmonary function (as measured by peak oxygen consumption
[VO2peak]) across the breast cancer continuum and its prognostic significance in women …

Adjuvant radiation therapy in the management of early stage breast cancer, Hodgkin's
disease, and to a lesser extent other thoracic malignancies has led to a significant …

The literature is reviewed to identify the main clinical and dose–volume predictors for acute
and late radiation-induced heart disease. A clear quantitative dose and/or volume …